Q32 BioFRA:DB0 -0.18%17 PB Ratio is 4.14 as of Jul. 07, 2026, which is 107% above its 10-year median of 2.00. GuruFocus rates FRA:DB0 with a GF Score™ of 17/100. The stock has 6 warning signs investors should review. Among 1,226 Biotechnology companies, Q32 Bio ranks worse than 62.4% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-07), Q32 Bio's share price is €11.33. Q32 Bio's Book Value per Share for the quarter that ended in Mar. 2026 was €2.74. Hence, Q32 Bio's PB Ratio of today is 4.14.
Warning Sign:
Q32 Bio Inc stock PB Ratio (=4.15) is close to 1-year high of 4.16.
The historical rank and industry rank for Q32 Bio's PB Ratio or its related term are showing as below:
FRA:DB0'
s PB Ratio Range Over the Past 10 Years
Min: 0.96 Med: 2 Max: 33.57
Current: 4.14
During the past 5 years, Q32 Bio's highest PB Ratio was 33.57. The lowest was 0.96. And the median was 2.00.
FRA:DB0's PB Ratio is ranked worse than 62.4% of 1226
companies
in the Biotechnology industry
Industry Median: 2.91
vs FRA:DB0: 4.14
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Q32 Bio PB Ratio Related Terms
Q32 Bio PB Ratio Historical Data
* Premium members only.
The historical data trend for Q32 Bio's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Q32 Bio's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Q32 Bio PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Q32 Bio's PB Ratio distribution charts can be found below:
* The bar in red indicates where Q32 Bio's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Q32 Bio's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Q32 Bio (FRA:DB0) has a PB Ratio of 4.14 as of Jul. 07, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Q32 Bio and its competitors. This is 107% above median its historical median of 2.00. Over the past decade, Q32 Bio's PB Ratio has ranged from 0.96 to 33.57. According to the industry distribution chart, Q32 Bio ranks #765 out of 1226 companies in the Biotechnology industry, placing it in the top 62.4%.
Is Q32 Bio's PB Ratio too high?
Q32 Bio's current PB Ratio of 4.14 is 107% above median its 10-year median of 2.00. Over the past 10 years, this metric has ranged from a low of 0.96 to a high of 33.57. The Biotechnology industry median PB Ratio is 2.91. Q32 Bio's value of 4.14 is 42.3% above this industry median. Based on the distribution chart, Q32 Bio ranks #765 out of 1226 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Q32 Bio has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Q32 Bio's PB Ratio compare to CAMP and CDXS?
According to the Biotechnology industry distribution chart, Q32 Bio ranks #765 out of 1226 companies for PB Ratio. This places Q32 Bio in the lower half of its industry. The industry median PB Ratio is 2.91. Q32 Bio's value of 4.14 is 42.3% above this benchmark. Historically, Q32 Bio's own PB Ratio has ranged from 0.96 to 33.57 over the past decade. While the company's 10-year median is 2.00 vs. the industry median of 2.91, Q32 Bio has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.91, based on 1,226 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Q32 Bio's current PB Ratio of 4.14 is 42.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Q32 Bio and its competitors. For the Biotechnology industry, the median PB Ratio is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Q32 Bio's current PB Ratio is 4.14, which is 107% above median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q32 Bio stock overvalued right now?
Q32 Bio (FRA:DB0) has a current PB Ratio of 4.14. The current PB Ratio is 4.14, which is 107% above median its 10-year median of 2.00 and 42.3% above the Biotechnology industry median of 2.91. Q32 Bio's overall GF Score™ is 17/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Q32 Bio (FRA:DB0), the current PB Ratio is 4.14 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
17GF Score
Get the complete analysis for FRA:DB0
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:DB0 has been successfully added to your 
